rdf:type |
|
lifeskim:mentions |
umls-concept:C0003864,
umls-concept:C0004358,
umls-concept:C0012854,
umls-concept:C0020861,
umls-concept:C0205210,
umls-concept:C0205263,
umls-concept:C0205460,
umls-concept:C0443146,
umls-concept:C0666743,
umls-concept:C0717758,
umls-concept:C1542147
|
pubmed:issue |
7
|
pubmed:dateCreated |
2005-7-4
|
pubmed:abstractText |
To analyze the clinical and biologic correlates of autoantibody induction during longer-term tumor necrosis factor alpha (TNFalpha) blockade with either the monoclonal antibody infliximab or the soluble receptor etanercept.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antinuclear,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0004-3591
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2192-201
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15986349-Adult,
pubmed-meshheading:15986349-Aged,
pubmed-meshheading:15986349-Antibodies, Antinuclear,
pubmed-meshheading:15986349-Antibodies, Monoclonal,
pubmed-meshheading:15986349-Antirheumatic Agents,
pubmed-meshheading:15986349-DNA,
pubmed-meshheading:15986349-Drug Therapy, Combination,
pubmed-meshheading:15986349-Female,
pubmed-meshheading:15986349-Humans,
pubmed-meshheading:15986349-Immunoglobulin G,
pubmed-meshheading:15986349-Immunoglobulin M,
pubmed-meshheading:15986349-Male,
pubmed-meshheading:15986349-Middle Aged,
pubmed-meshheading:15986349-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:15986349-Spondylitis, Ankylosing,
pubmed-meshheading:15986349-Tumor Necrosis Factor-alpha
|
pubmed:year |
2005
|
pubmed:articleTitle |
Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.
|
pubmed:affiliation |
Department of Rheumatology, Ghent University Hospital, Ghent, Belgium. Leen.DeRycke@UGent.be
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|